NRGene Technologies Ltd. Logo

NRGene Technologies Ltd.

AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.

NRGN | TA

Overview

Corporate Details

ISIN(s):
IL0011720716
LEI:
Country:
Israel
Address:
5 Golda Meir Street, 7403649 Ness Ziona
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NRGene Technologies Ltd. is an agricultural technology (AgTech) company that develops and commercializes artificial intelligence-based software and genomic analysis tools. The company provides turn-key solutions that analyze large-scale genomic data to accelerate and optimize natural breeding processes for plants and animals. Its proprietary algorithms and platforms are utilized by leading breeding companies, seed developers, and agricultural organizations to enhance crop and livestock development, discover novel genetic traits, and improve food production sustainability. NRGene's core offerings include comprehensive genotyping solutions and genomic big data analytics designed to reveal genetic complexity and diversity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-09 20:13
Regulatory News Service
Following the completion of its contracted two-year engagement under the Tel Av…
Hebrew (modern) 174.5 KB
2023-08-09 20:13
Business and Financial Review
Following the completion of its contracted two-year engagement under the Tel Av…
Russian 46.0 KB
2023-05-22 23:48
Management Discussion and Analysis
Analysis update report, target price remains 19.8 NIS
English 969.2 KB
2023-05-22 23:48
Earnings Release
Analysis update report, target price remains 19.8 NIS
Russian 70.9 KB
2023-04-13 20:31
Earnings Release
Analysis update - target price t is updated to NIS 19.8
English 959.3 KB
2023-04-13 20:31
Regulatory News Service
Analysis update - target price t is updated to NIS 19.8
Russian 67.3 KB
2022-12-11 20:51
Business and Financial Review
Analysis update report, target price remains 30.9NIS
English 1.1 MB
2022-12-11 20:51
Report Publication Announcement
Analysis update report, target price remains 30.9NIS
Russian 64.0 KB
2022-09-13 22:01
Investor Presentation
update Analysis (FROST) following financial report, target price remains NIS 30…
English 1.2 MB
2022-09-13 22:01
Report Publication Announcement
update Analysis (FROST) following financial report, target price remains NIS 30…
Russian 60.5 KB
2022-08-15 21:22
Investor Presentation
Investors Presentation - August 2022
English 2.5 MB
2022-08-15 21:22
Report Publication Announcement
Investors Presentation - August 2022
Russian 41.9 KB
2022-05-31 21:47
Investor Presentation
Analysis update report, target price remains 30.9NIS
English 1.1 MB
2022-05-31 21:47
Report Publication Announcement
Analysis update report, target price remains 30.9NIS
Russian 55.2 KB
2022-04-03 22:30
Regulatory News Service
Quarterly analysis update report, target price remains 30.9NIS
English 1.1 MB

Automate Your Workflow. Get a real-time feed of all NRGene Technologies Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NRGene Technologies Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NRGene Technologies Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France ALHYG
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea 101140
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea 216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.